Clinical trial
Tenofovir Disoproxil Fumarate to Treat Pediatric HIV
NCT00024986 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00024986 |
|---|---|
| Title | Tenofovir Disoproxil Fumarate to Treat Pediatric HIV |
| Official title | A Phase I Study of Tenofovir Disoproxil Fumarate (PMPA Prodrug), A Novel Nucleotide Analog Reverse Transcriptase Inhibitor in Children With HIV Infection |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Drug |
| Interventions | Tenofovir DF |
| Enrollment | 30 |
| Start date | Oct 1, 2001 |
| Completion | Sep 1, 2005 |
| First posted | Oct 11, 2001 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: